EA200200375A1 - Содержащая циклезонид фармацевтическая композиция, предназначенная для нанесения на слизистую оболочку - Google Patents

Содержащая циклезонид фармацевтическая композиция, предназначенная для нанесения на слизистую оболочку

Info

Publication number
EA200200375A1
EA200200375A1 EA200200375A EA200200375A EA200200375A1 EA 200200375 A1 EA200200375 A1 EA 200200375A1 EA 200200375 A EA200200375 A EA 200200375A EA 200200375 A EA200200375 A EA 200200375A EA 200200375 A1 EA200200375 A1 EA 200200375A1
Authority
EA
Eurasian Patent Office
Prior art keywords
intended
pharmaceutical composition
ciclesonide
cyclesonide
sledge
Prior art date
Application number
EA200200375A
Other languages
English (en)
Other versions
EA006015B1 (ru
Inventor
Атсухиро Нагано
Ёшихиса Нишибе
Казуя Таканаши
Original Assignee
Бык Гульден Ломберг Хемише Фабрик Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17856327&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200200375(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Бык Гульден Ломберг Хемише Фабрик Гмбх filed Critical Бык Гульден Ломберг Хемише Фабрик Гмбх
Publication of EA200200375A1 publication Critical patent/EA200200375A1/ru
Publication of EA006015B1 publication Critical patent/EA006015B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

В заявке описана фармацевтическая композиция, предназначенная для нанесения на слизистую оболочку, которую можно применять для фармакотерапии и которая включает водонерастворимое и/или мало растворимое в воде вещество, циклезонид и водную среду и имеет осмотическое давление менее 290 мО/см. Эта композиция обладает преимуществом по сравнению с общепринятыми фармацевтическими композициями, предназначенными для нанесения на слизистую оболочку, которое обусловлено эффективной и высокой способностью циклезонида удерживаться в слизистой оболочке и способностью циклезонида проникать в подслизистую основу и кровеносную систему слизистой оболочки.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200200375A 1999-10-20 2000-10-20 Содержащая циклезонид фармацевтическая композиция, предназначенная для нанесения на слизистую оболочку EA006015B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29818599 1999-10-20
PCT/JP2000/007350 WO2001028562A1 (en) 1999-10-20 2000-10-20 Ciclesonide contained pharmaceutical composition for application to mucosa

Publications (2)

Publication Number Publication Date
EA200200375A1 true EA200200375A1 (ru) 2002-10-31
EA006015B1 EA006015B1 (ru) 2005-08-25

Family

ID=17856327

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200375A EA006015B1 (ru) 1999-10-20 2000-10-20 Содержащая циклезонид фармацевтическая композиция, предназначенная для нанесения на слизистую оболочку

Country Status (35)

Country Link
US (1) US6767901B1 (ru)
EP (1) EP1225902B1 (ru)
JP (1) JP4264211B2 (ru)
KR (1) KR100722209B1 (ru)
CN (2) CN101869570B (ru)
AR (1) AR026072A1 (ru)
AT (1) ATE285779T1 (ru)
AU (1) AU781895B2 (ru)
BG (1) BG65818B1 (ru)
BR (1) BRPI0014878B8 (ru)
CA (1) CA2388322C (ru)
CO (1) CO5261494A1 (ru)
CZ (1) CZ297779B6 (ru)
DE (1) DE60017175T2 (ru)
DK (1) DK1225902T3 (ru)
EA (1) EA006015B1 (ru)
ES (1) ES2234681T3 (ru)
HR (1) HRP20020346B1 (ru)
HU (1) HU228893B1 (ru)
IL (2) IL148691A0 (ru)
ME (1) ME00567B (ru)
MX (1) MXPA02003974A (ru)
MY (1) MY136987A (ru)
NO (1) NO327444B1 (ru)
NZ (1) NZ518298A (ru)
PE (1) PE20010712A1 (ru)
PL (1) PL199702B1 (ru)
PT (1) PT1225902E (ru)
RS (1) RS50310B (ru)
SI (1) SI1225902T1 (ru)
SK (1) SK286196B6 (ru)
TR (1) TR200200841T2 (ru)
TW (1) TWI225788B (ru)
WO (1) WO2001028562A1 (ru)
ZA (1) ZA200203077B (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
EP3513813A1 (en) * 2002-07-02 2019-07-24 Astrazeneca Ciclesonide-containing sterile aqueous suspension
US7221586B2 (en) 2002-07-08 2007-05-22 Micron Technology, Inc. Memory utilizing oxide nanolaminates
BR0312849A (pt) * 2002-07-26 2005-04-19 Fmc Corp Produção de celulose microcristalina
CA2495830C (en) * 2002-08-30 2012-08-21 Altana Pharma Ag The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis
US7879833B2 (en) * 2002-12-12 2011-02-01 Nycomed Gmbh Combination medicament
MY143936A (en) 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
PT1670482E (pt) * 2003-09-16 2014-03-12 Takeda Gmbh Utilização de ciclesonida para o tratamento de doenças respiratórias
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
US20070134165A1 (en) * 2004-04-20 2007-06-14 Altana Pharma Ag Use of Ciclesonide for the Treatment of Respiratory Disease in a Smoking Patient
CA2579007A1 (en) * 2004-09-10 2006-03-16 Altana Pharma Ag Ciclesonide and syk inhibitor combination and methods of use thereof
EP1645266A1 (en) * 2004-10-08 2006-04-12 Hisamitsu Medical Co., Ltd. Aqueous suspension for nasal drops
MX2010009961A (es) * 2008-03-14 2010-09-30 Cephalon Inc Composicion transmucosica mejorada y forma de dosificacion.
WO2011135585A2 (en) 2010-04-28 2011-11-03 Cadila Healthcare Limited Aqueous pharmaceutical solution of ciclesonide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63303931A (ja) * 1987-06-05 1988-12-12 Sumitomo Pharmaceut Co Ltd 経鼻投与用成長ホルモン放出活性物質製剤
GB9103824D0 (en) 1991-02-23 1991-04-10 Fisons Ag Formulation
WO1997001337A1 (en) 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. The combination of topical nasal antihistamines and topical nasal steroids
US6120752A (en) * 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
SE9704186D0 (sv) * 1997-11-14 1997-11-14 Astra Ab New composition of matter
CN1158995C (zh) * 1998-01-22 2004-07-28 参天制药株式会社 氟米龙眼用混悬液
SE514128C2 (sv) * 1998-03-17 2001-01-08 Pharmalink Ab Användning av en glukokortikoid för framställning av ett läkemedel för behandling av glomerulonefrit
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa

Also Published As

Publication number Publication date
CO5261494A1 (es) 2003-03-31
AU7953100A (en) 2001-04-30
SI1225902T1 (en) 2005-06-30
MY136987A (en) 2008-12-31
CZ20021238A3 (cs) 2002-07-17
CN1379674B (zh) 2014-10-29
CA2388322A1 (en) 2001-04-26
BR0014878A (pt) 2002-06-11
EA006015B1 (ru) 2005-08-25
CN1379674A (zh) 2002-11-13
JP4264211B2 (ja) 2009-05-13
US6767901B1 (en) 2004-07-27
NO327444B1 (no) 2009-06-29
KR20020059627A (ko) 2002-07-13
NZ518298A (en) 2003-11-28
AU781895B2 (en) 2005-06-23
ME00567A (en) 2011-12-20
ME00567B (me) 2011-12-20
WO2001028562A1 (en) 2001-04-26
HK1149719A1 (en) 2011-10-14
YU28002A (sh) 2004-11-25
IL148691A (en) 2006-12-10
HU228893B1 (hu) 2013-06-28
HK1050858A1 (zh) 2003-07-11
DE60017175D1 (de) 2005-02-03
DE60017175T2 (de) 2005-12-29
ES2234681T3 (es) 2005-07-01
BRPI0014878B1 (pt) 2015-08-11
CA2388322C (en) 2007-09-18
CN101869570B (zh) 2012-10-10
AR026072A1 (es) 2002-12-26
BG65818B1 (bg) 2010-01-29
JP2003512329A (ja) 2003-04-02
PT1225902E (pt) 2005-05-31
SK6922002A3 (en) 2002-09-10
SK286196B6 (sk) 2008-05-06
EP1225902A1 (en) 2002-07-31
PL356191A1 (en) 2004-06-14
DK1225902T3 (da) 2005-05-02
ATE285779T1 (de) 2005-01-15
MXPA02003974A (es) 2003-09-25
HUP0203339A3 (en) 2004-07-28
KR100722209B1 (ko) 2007-05-29
BRPI0014878B8 (pt) 2021-05-25
IL148691A0 (en) 2002-09-12
HRP20020346A2 (en) 2004-02-29
RS50310B (sr) 2009-09-08
NO20021898L (no) 2002-04-22
TWI225788B (en) 2005-01-01
HRP20020346B1 (hr) 2011-06-30
PL199702B1 (pl) 2008-10-31
CZ297779B6 (cs) 2007-03-28
ZA200203077B (en) 2003-02-26
NO20021898D0 (no) 2002-04-22
EP1225902B1 (en) 2004-12-29
HUP0203339A2 (hu) 2003-02-28
PE20010712A1 (es) 2001-07-12
BG106512A (bg) 2002-12-29
TR200200841T2 (tr) 2002-07-22
CN101869570A (zh) 2010-10-27

Similar Documents

Publication Publication Date Title
EA200000060A1 (ru) Фармацевтические композиции для нанесения на слизистую оболочку
EA200200375A1 (ru) Содержащая циклезонид фармацевтическая композиция, предназначенная для нанесения на слизистую оболочку
CA2274485A1 (en) Medicinal composition
NO970361D0 (no) Spraybart filmdannende system som frigjör aktive stoffer for anvendelse på planter
CA2430288A1 (en) A composition improved in the solubility or oral absorbability
FR2443244A1 (fr) Excipient pharmaceutique et composition pharmaceutique renfermant cet excipient
EP0985347A4 (en) EFFERVESCENT PREPARATION FOR PLANTS
ATE426006T1 (de) Pigmentpraparation
CA2326840A1 (en) Carvedilol-galenics
PT1091740E (pt) Preparacoes aquosas semi-solidas para administracao oral de toltrazuril-sulfona
CA2247107A1 (en) Releasant for aqueous polymer-type floor polish
JPS5540604A (en) Improved local topicum
BR0011864A (pt) Formulações farmacêuticas
FI118953B (fi) Ulkoisesti käytettävä, nimesulidia käsittävä tulehdusta torjuva aine
DE69617868D1 (de) Geschmacksmaskierte wässrige Lösungen enthaltend Ibuprofen und Menthol
RU2001120110A (ru) Фармацевтическая смесь, содержащая профен
RU97114327A (ru) Антисептический препарат "лизанин оп"
FR2821552B1 (fr) Procede pour rendre hydrosoluble un principe actif naturellement peu ou pas soluble dans l'eau et ses utilisations
JPS57108011A (en) Film-forming endermic liniment
RU2001117147A (ru) Ранозаживляющее средство - "мазь тиотриазолина"
MY124416A (en) Pharmaceutical composition for application to mucosa
RU2002111826A (ru) Ноотропное средство "Ноотобрил" в форме раствора для инъекций
DK559983A (da) Gelpraeparater til ekstern administration
KR920007620A (ko) 실리마린 및 약학 또는 화장품조성물의 용해방법
RU94001451A (ru) Препарат для массажа "малавит"

Legal Events

Date Code Title Description
PD1A Registration of transfer to a eurasian application by order of succession in title
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

PD4A Registration of transfer of a eurasian patent in accordance with the succession in title
PD4A Registration of transfer of a eurasian patent in accordance with the succession in title
PD4A Registration of transfer of a eurasian patent in accordance with the succession in title
PD4A Registration of transfer of a eurasian patent in accordance with the succession in title
TC4A Change in name of a patent proprietor in a eurasian patent
PC4A Registration of transfer of a eurasian patent by assignment
PC4A Registration of transfer of a eurasian patent by assignment
MK4A Patent expired

Designated state(s): BY RU